pharma news today obesity drugs glp-1 today ๐ The next trillion-dollar drug war has begun Drugmakers including Eli Lilly, Novo Nordisk, Pfizer, Amgen, AstraZeneca and others are racing beyond today's drugs. New pills, monthly injections and next-generation GLP-1s and the Unintended Consequences
Description
10.1016/j.neuropharm.2011.12.022 64 KeatingG
Slowing gastric emptying: GLP-1 slows down how quickly food moves from the stomach to the intestines, which helps promote satiety (feeling full) and can aid in weight loss
Diabetes Obes Metab (2011) 13:42633
4.4 Potential effects of tirzepatide on upper airway function In addition to metabolic and inflammatory modulation, emerging evidence suggests that incretin-based therapies may influence upper airway neuromuscular control
In lower-income states like Mississippi, Louisiana, and West Virginia, not so much but it depends on the price tag people are willing to put on feeling or looking healthier
The Mller group receives funding for basic science from Novo Nordisk
